{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:05:13Z","timestamp":1762761913929},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41429-022-00530-w","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T06:03:04Z","timestamp":1652421784000},"page":"403-409","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro activity of ceragenins against Burkholderia cepacia complex"],"prefix":"10.1038","volume":"75","author":[{"given":"Elif Sena","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Oyardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Havva Ozlem","family":"Altay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagla","family":"Bozkurt-Guzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"530_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5578\/mb.67730","volume":"53","author":"O Akisoglu","year":"2019","unstructured":"Akisoglu O, Engin D, Saricam S, Mustak H, Sener B, Hascelik G. Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis. Mikrobiyol Bul. 2019;53:22\u201336.","journal-title":"Mikrobiyol Bul"},{"key":"530_CR2","first-page":"115","volume":"40","author":"WH Burkholder","year":"1950","unstructured":"Burkholder WH. Sour skin, a bacterial rot of onion bulbs. Phytopathology. 1950;40:115\u20137.","journal-title":"Phytopathology"},{"key":"530_CR3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1348-0421.1992.tb02129.x","volume":"36","author":"E Yabuuchi","year":"1992","unstructured":"Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Pallerioni and Holmes 1981) comb. nov. Microbiol Immunol. 1992;36:1251\u201375.","journal-title":"Microbiol Immunol"},{"key":"530_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","volume":"28","author":"KA Rhodes","year":"2016","unstructured":"Rhodes KA, Schweizer HP. Antibiotic Resistance in Burkholderia Species. Drug Resist Updat. 2016;28:82\u201390.","journal-title":"Drug Resist Updat"},{"key":"530_CR5","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"MP Weinstein","year":"2018","unstructured":"Weinstein MP, et al. Performance standards for antimicrobial susceptibility testing. 28th ed. Wayne, PA: Clinical and Laboratory Standards Institute;; 2018. CLSI Supplement M100","edition":"28th ed."},{"key":"530_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1021\/ar700270t","volume":"41","author":"XZ Lai","year":"2008","unstructured":"Lai XZ, Feng Y, Pollard J, Chin JN, Rybak MJ, Bucki R, et al. Ceragenins: cholic acid- based mimics of antimicrobial peptids. Acc Chem Res. 2008;41:1233\u201340.","journal-title":"Acc Chem Res"},{"key":"530_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1128\/mr.56.3.395-411.1992","volume":"56","author":"M Vaara","year":"1992","unstructured":"Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992;56:395\u2013411.","journal-title":"Microbiol Rev"},{"key":"530_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1021\/ja982938m","volume":"121","author":"C Li","year":"1999","unstructured":"Li C, Budge LP, Driscoll CD, Willardson BM, Allman GW, Savage PB. Incremental conversion of outer membrane permeabilizers into potent antibiotics for Gram-negative bacteria. J Am Chem Soc. 1999;121:931\u201340.","journal-title":"J Am Chem Soc"},{"key":"530_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/jac\/47.5.671","volume":"47","author":"EJ Schmidt","year":"2001","unstructured":"Schmidt EJ, Boswell JS, Walsh JP, Schellenberg MM, Winter TW, Li C, et al. Activities of cholic acid-derived antimicrobial agents against multidrug-resistant bacteria. J Antimicrobial Chem. 2001;47:671\u20134.","journal-title":"J Antimicrobial Chem"},{"key":"530_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/molecules23030596","volume":"23","author":"MM Hashemi","year":"2018","unstructured":"Hashemi MM, Holden BS, Taylor MF, Wilson J, Coburn J, Hilton B, et al. Antibacterial and antifungal activities of poloxamer micelles containing ceragenin CSA-131 on ciliated tissues. Molecules. 2018;23:596.","journal-title":"Molecules"},{"key":"530_CR11","first-page":"CS009876","volume":"4","author":"KH Regan","year":"2019","unstructured":"Regan KH, Bhatt J. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. Cochrane Database of Syst Rev. 2019;4:CS009876.","journal-title":"Cochrane Database of Syst Rev"},{"key":"530_CR12","volume-title":"Methods for determining a bactericidal activity of antimicrobial agents","author":"AL Barry","year":"1999","unstructured":"Barry AL, et al. Methods for determining a bactericidal activity of antimicrobial agents. 19th ed. Wayne, PA: Clinical and Laboratory Standards Institute;; 1999. Approved Guideline M26-A NCCLS","edition":"19th ed."},{"key":"530_CR13","doi-asserted-by":"crossref","unstructured":"Soussa SA, Ramos CG, Leitao JH Burkholderia cepacia Complex: Emerging Multihost pathogens Equipped with a Wide Range of Virulence Factors and Determinants. Int J Microbiol 2011; pii: 607575.","DOI":"10.1155\/2011\/607575"},{"key":"530_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1099\/jmm.0.000458","volume":"66","author":"DTD Kenna","year":"2017","unstructured":"Kenna DTD, Lilley D, Coward A, Martin K, Perry C, Pike R, et al. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J Med Microbiol. 2017;66:490\u2013501.","journal-title":"J Med Microbiol"},{"key":"530_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00284-020-01949-w","volume":"77","author":"C Bozkurt- Guzel","year":"2020","unstructured":"Bozkurt- Guzel C, Inci G, Oyardi O, Savage PB. Synergistic acitivity of ceragenins against Carbapenem- Resistant Acinetobacter baumannii isolates in both checkerboard and dynamic Time-Kill assays. Curr Microbiol. 2020;77:1419\u201328.","journal-title":"Curr Microbiol"},{"key":"530_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jac\/dkaa434","volume":"76","author":"O Oyardi","year":"2021","unstructured":"Oyardi O, Savage PB, Erturan Z, Bozkurt-Guzel C. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis. J Antimicrob Chemother. 2021;76:443\u201350.","journal-title":"J Antimicrob Chemother"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00530-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T06:04:02Z","timestamp":1654495442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-022-00530-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1038\/s41429-022-00530-w","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}